Christian Ehmann
Stock Analyst at Berenberg Bank
(0.46)
# 4,205
Out of 4,581 analysts
188
Total ratings
42.2%
Success rate
-4%
Average return
Main Sectors:
Stocks Rated by Christian Ehmann
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: EVT Evotec SE | Downgraded: Hold | €9.70 → €3.60 | €3.51 | +2.51% | 39 | Jul 16, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Buy | €22.00 → €24.00 | €21.20 | +13.21% | 7 | Jul 10, 2026 | |
| SWX: KURN Kuros Biosciences AG | Initiated Coverage: Buy | CHF 32.00 | CHF 23.34 | +37.10% | 1 | Jul 7, 2026 | |
| ETR: GXI Gerresheimer AG | Maintained: Hold | €20.00 → €24.00 | €29.60 | -18.92% | 14 | Jul 3, 2026 | |
| ETR: DMP Dermapharm Holding SE | Maintained: Hold | €41.00 | €41.80 | -1.91% | 4 | Aug 26, 2025 | |
| ETR: FYB Formycon AG | Maintained: Buy | €40.00 | €19.20 | +108.33% | 14 | Aug 13, 2025 | |
| ETR: DRW3 Drägerwerk AG & Co. KGaA | Maintained: Buy | €85.00 | €96.00 | n/a | 21 | Jul 14, 2025 | |
| ETR: FRE Fresenius SE & Co. KGaA | Maintained: Buy | €47.00 | €44.44 | n/a | 23 | May 7, 2025 | |
| ETR: M12 M1 Kliniken AG | Maintained: Buy | €26.00 → €28.00 | €17.90 | n/a | 15 | May 6, 2025 | |
| ETR: FME Fresenius Medical Care AG | Maintained: Hold | €43.00 | €43.68 | n/a | 20 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.80 → €5.90 | €2.72 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €5.60 | €2.94 | n/a | 1 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.50 → €17.90 | €0.95 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €30.00 → €33.00 | €13.00 | n/a | 10 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €41.00 → €56.00 | €1.18 | n/a | 2 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €4.20 → €3.50 | €0.02 | n/a | 3 | May 5, 2022 |
Evotec SE
Jul 16, 2026
Downgraded: Hold
Price Target: €9.70 → €3.60
Current: €3.51
Upside: +2.51%
SCHOTT Pharma AG & Co. KGaA
Jul 10, 2026
Maintained: Buy
Price Target: €22.00 → €24.00
Current: €21.20
Upside: +13.21%
Kuros Biosciences AG
Jul 7, 2026
Initiated Coverage: Buy
Price Target: CHF 32.00
Current: CHF 23.34
Upside: +37.10%
Gerresheimer AG
Jul 3, 2026
Maintained: Hold
Price Target: €20.00 → €24.00
Current: €29.60
Upside: -18.92%
Dermapharm Holding SE
Aug 26, 2025
Maintained: Hold
Price Target: €41.00
Current: €41.80
Upside: -1.91%
Formycon AG
Aug 13, 2025
Maintained: Buy
Price Target: €40.00
Current: €19.20
Upside: +108.33%
Drägerwerk AG & Co. KGaA
Jul 14, 2025
Maintained: Buy
Price Target: €85.00
Current: €96.00
Upside: n/a
Fresenius SE & Co. KGaA
May 7, 2025
Maintained: Buy
Price Target: €47.00
Current: €44.44
Upside: n/a
M1 Kliniken AG
May 6, 2025
Maintained: Buy
Price Target: €26.00 → €28.00
Current: €17.90
Upside: n/a
Fresenius Medical Care AG
Feb 25, 2025
Maintained: Hold
Price Target: €43.00
Current: €43.68
Upside: n/a
Nov 11, 2024
Maintained: Buy
Price Target: €12.80 → €5.90
Current: €2.72
Upside: n/a
Feb 7, 2024
Maintained: Hold
Price Target: €5.60
Current: €2.94
Upside: n/a
Dec 14, 2023
Maintained: Buy
Price Target: €16.50 → €17.90
Current: €0.95
Upside: n/a
Nov 21, 2023
Maintained: Buy
Price Target: €30.00 → €33.00
Current: €13.00
Upside: n/a
May 30, 2023
Maintained: Buy
Price Target: €41.00 → €56.00
Current: €1.18
Upside: n/a
May 5, 2022
Maintained: Buy
Price Target: €4.20 → €3.50
Current: €0.02
Upside: n/a